Year |
Citation |
Score |
2009 |
Shirali A, Sriram M, Hall JJ, Nguyen BL, Guddneppanavar R, Hadimani MB, Ackley JF, Siles R, Jelinek CJ, Arthasery P, Brown RC, Murrell VL, McMordie A, Sharma S, Chaplin DJ, et al. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P. Journal of Natural Products. 72: 414-21. PMID 19161336 DOI: 10.1021/Np800661R |
0.367 |
|
2008 |
Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents. Journal of Natural Products. 71: 313-20. PMID 18303849 DOI: 10.1021/Np070377J |
0.715 |
|
2007 |
Trawick ML, Arispe‐Angulo WM, Chen S, Siles R, Zhou M, Pinney KG. Kinetics of Thiosemicarbazone‐Based Inhibitors of Cathepsin L The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A642-A |
0.544 |
|
2006 |
Siles R, Chen SE, Zhou M, Pinney KG, Trawick ML. Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. Bioorganic & Medicinal Chemistry Letters. 16: 4405-9. PMID 16781147 DOI: 10.1016/J.Bmcl.2006.05.041 |
0.671 |
|
2006 |
Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents. Bioorganic & Medicinal Chemistry. 14: 3231-44. PMID 16442292 DOI: 10.1016/J.Bmc.2005.12.033 |
0.769 |
|
2003 |
Monk KA, Siles R, Pinney KG, Garner CM. Synthesis of 4-methoxy-3,5-dinitrobenzaldehyde: A correction to supposed tele nucleophilic aromatic substitution Tetrahedron Letters. 44: 3759-3761. DOI: 10.1016/S0040-4039(03)00751-2 |
0.674 |
|
Show low-probability matches. |